Edward P. Jordan

Insider Reports History

Entity
Individual
Location
C/O Amag Pharmaceuticals, Inc., 1100 Winter Street, Waltham, MA
Signature
/s/ Henry Madrid, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Edward P. Jordan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HUMANIGEN, INC Chief Commercial Officer Stock Option (Right to Buy) 455K $2.06M $4.53 Jul 27, 2022 Direct

Insider Reports Filed by Edward P. Jordan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HGEN HUMANIGEN, INC Jul 27, 2022 1 $0 4 Jul 29, 2022 Chief Commercial Officer
HGEN HUMANIGEN, INC Mar 2, 2022 1 $29K 4 Mar 4, 2022 Chief Commercial Officer
HGEN HUMANIGEN, INC Jan 12, 2022 1 $0 4 Jan 14, 2022 Chief Commercial Officer
HGEN HUMANIGEN, INC Dec 31, 2021 1 $0 4 Jan 4, 2022 Chief Commercial Officer
HGEN HUMANIGEN, INC Nov 23, 2021 1 -$22.5K 4 Nov 26, 2021 Chief Commercial Officer
HGEN HUMANIGEN, INC Sep 30, 2021 1 $0 4 Oct 4, 2021 Chief Commercial Officer
HGEN HUMANIGEN, INC Jun 8, 2021 3 -$153K 4 Jun 9, 2021 Chief Commercial Officer